Find clinical trials for Non-Small-Cell Lung Cancer in Philadelphia, PA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Non-Small-Cell Lung Cancer trials near Philadelphia, PA, USA:
This is a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non...
Phase 2
Camden, New Jersey, United States and 72 other locations
HCC is a common cancer worldwide and a leading cause of cancer-related death. Lung cancer is the most frequently ...
Phase 1
Philadelphia, Pennsylvania, United States and 21 other locations
Researchers are investigating new treatments for untreated advanced non-small cell lung cancer (NSCLC), ...
Phase 2
Philadelphia, Pennsylvania, United States of America and 40 other locations
and osimertinib in subjects with locally advanced or metastatic non-small cell lung cancer (NSCLC) with ...
Phase 1
Philadelphia, Pennsylvania, United States and 30 other locations
This study is designed to identify the target Non-Small Cell Lung Cancer (NSCLC) population(s) that over...
Phase 2
Pennington, New Jersey, United States and 254 other locations
The purpose of ARTEMIDE-Lung02 is to assess the efficacy and safety of rilvegostomig in combination with platinum-based chemotherapy for the-...
Phase 3
Camden, New Jersey, United States and 327 other locations
combination with standard of care carboplatin and pemetrexed) in 21 day treatment cycle for participants with advanced non-small c ...
Phase 1
Philadelphia, Pennsylvania, United States and 71 other locations
alone for the treatment of locally advanced or metastatic non-small cell lung cancer. Some lung ...
Phase 3
Philadelphia, Pennsylvania, United States and 152 other locations
This study will evaluate two study drugs called ubamatamab and marlotamig, to see if they can help treat advanced or metastatic Non-Small...
Phase 2
Newark, Delaware, United States and 16 other locations
This is a Phase III, randomised, double-blind, multicentre, international study assessing the efficacy and safety of durvalumab (MEDI4736) in combina...
Phase 3
Philadelphia, Pennsylvania, United States and 201 other locations
Clinical trials
Research sites
Resources
Legal